MedTrace Logo

To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System

NCT07098195 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2025-08-01

No results posted yet for this study

Summary

The study will evaluate the performance and safety of RisoR Crest Everolimus Eluting Coronary Stent System. A total of 2000 participants will be included in the study from India and Italy.

Conditions

  • Coronary Artery Disease
  • Coronary Artery Stenosis
  • Percutaneous Coronary Intervention
  • de Novo Lesions in Native Coronary Arteries

Interventions

DEVICE

Coronary Stent

RisoR Crest Everolimus Eluting Coronary Stent System

Sponsors & Collaborators

  • Poly Medicure Limited

    lead INDUSTRY

Principal Investigators

  • Dr. Praveen Chandra, DM Cardiology · Medanta-The Medicity, Gurugram, Haryana, India

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-18
Primary Completion
2027-08-17
Completion
2028-01-17

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07098195 on ClinicalTrials.gov